Results 231 to 240 of about 57,297 (272)

Comparative Analysis of Hypothalamic Responses to Stress and Glutamine Supplementation in Diet-Induced Obese Mice: A Study of Sex Differences. [PDF]

Inflammation
Dreux V, Lefebvre C, Breemeersch CE, Tiffay A, Déchelotte P, Goichon A, Langlois L, Coëffier M.   +7 more
europepmc   +1 more source

OPTN protects retinal ganglion cells and ameliorates neuroinflammation in optic neuropathies. [PDF]

Commun Biol
Wang Q, Wang Y, Jiang YDD, Donahue R, Cao G, Yan W, Guo H, Li Z, Liang J, Hao J, Lu Y, Bei F, Wang Q, Tian F.   +13 more
europepmc   +1 more source

The pharmacotherapeutic potential of neuropeptide Y for chronic pain. [PDF]

J Intern Med
Nie AA, Taylor BK.
europepmc   +1 more source

Supplementary Figure S6 from <i>NPY</i> Methylated ctDNA is a Promising Biomarker for Treatment Response Monitoring in Metastatic Colorectal Cancer

Katleen Janssens, Greetje Vanhoutte, Willem Lybaert, Wim Demey, Jochen Decaestecker, Koen Hendrickx, Hassan Rezaei Kalantari, Karen Zwaenepoel, Patrick Pauwels, Erik Fransén, Ken Op de Beeck, Guy Van Camp, Christian Rolfo, Marc Peeters   +13 more
openalex   +1 more source

A parabrachial hub for need-state control of enduring pain. [PDF]

Nature
Goldstein N, Maes A, Allen HN, Nelson TS, Kruger KA, Kindel M, Yeung ATM, Smith NK, Carty JRE, Boccia L, Blank N, Lo E, Villari RE, Cho E, Marble EL, Awh M, Dumiaty Y, Chee MJ, Khanna R, Thaiss CA, Taylor BK, Kennedy A, Betley JN.   +22 more
europepmc   +1 more source

Transcriptome analysis of induced pluripotent stem cells' osteogenic differentiation reveals NPY1R activating PI3K/AKT/mTOR in alveolar bone loss during periodontitis. [PDF]

Am J Transl Res
Li X, Guo R, Liang L, Liang H, Zhou G, Lu Q, Huang Y, Qi Z, Li X.   +8 more
europepmc   +1 more source

Dual Targeting Approach Using 4-Hydroxytamoxifen Neuropeptide Y Conjugates for Selective Addressing of Adipose Tissue. [PDF]

ChemMedChem
Kohler A, Jülke EM, Darveniza LC, Stichel J, Beck-Sickinger AG.   +4 more
europepmc   +1 more source

Associations between serum neuropeptide Y levels and anxiety, depression, and quality of life in Chinese patients with primary glaucoma. [PDF]

BMC Ophthalmol
Cheng K, Quan F, Dai L, Gu C, Yu L.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

NPY and NPY Receptors in Vascular Remodeling

Current Topics in Medicinal Chemistry, 2007
Neuropeptide Y (NPY) is a sympathetic neurotransmitter that acts on multiple receptors (Y1-Y6) and exerts a variety of cardiovascular effects. Originally known as a vasoconstrictor acting on Y1 receptors, NPY is also a potent angiogenic factor as well as a powerful stimulator of vascular smooth muscle proliferation and atherogenesis in vitro and in ...
Ken, Abe, Jason U, Tilan, Zofia, Zukowska   +2 more
openaire   +2 more sources

Neuropeptide Y (NPY)

Pulmonary Pharmacology & Therapeutics, 2004
Neuropeptides such as neuropeptide Y (NPY) have long been proposed to play a role in the pathogenesis of inflammatory diseases. NPY is a 36 amino acid neuropeptide which participates in the regulation of a large number of physiological and pathophysiological processes in the cardiorespiratory system, immune system, nervous system and endocrine system ...
Groneberg, David A., Folkerts, Gert, Peiser, Christian, Chung, K. Fan, Fischer, Axel   +4 more
openaire   +2 more sources